SEC Form 4 · accession 0000904454-18-000360
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Blair
Director
Period of report
May 15, 2018
Accepted (ET)
May 17, 2018 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.35 | May 15, 2018 | A | 20,000 | A | — | May 15, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option vests in full on the earlier of the one-year anniversary of the date of grant or the Issuer's 2019 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.